The use of vaccines have resulted in a remarkable improvement in global health. It has
saved several lives, reduced treatment costs and raised the quality of animal and human …

Influenza virus has significant viral diversity, both through antigenic drift and shift, which
makes development of a vaccine challenging. Current influenza vaccines are updated …

Introduction A new body of evidence depicts the applications of artificial intelligence and
systems biology in vaccine design and development. The combination of both approaches …

The COVID-19 pandemic has led to over 2.26 million deaths for almost 104 million
confirmed cases worldwide, as of 4 February 2021 (WHO). Risk factors include pre-existing …

RNA viruses have high rate of replication and mutation that help them adapt and change
according to their environmental conditions. Many viral mutants are the cause of various …

This study was aimed to introduce a novel algorithm for determining linear B-and T-cell
epitopes from Crimean-Congo haemorrhagic fever virus (CCHFV) antigens. To this end, 387 …

Respiratory viruses continue to afflict mankind. Among them, pathogens such as
coronaviruses [including the current pandemic agent known as severe acute respiratory …

Replication of RNA viruses is characterized by exploration of sequence space which
facilitates their adaptation to changing environments. It is generally accepted that such …

Objective (s): Prevalence of influenza virus, creates the need to achieve an efficient vaccine
against it. We examined whether the predicted antigenic epitopes of HA, NP, and M2 …

Antibodies are fundamental tools for basic science; however, high-quality antibodies
suitable for multiple experimental applications are often inaccessible to research …